HighVista Strategies LLC - Q3 2023 holdings

$216 Million is the total value of HighVista Strategies LLC's 132 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 115.2% .

 Value Shares↓ Weighting
CPRI NewCAPRI HOLDINGS LIMITED$4,087,79777,700
+100.0%
1.89%
SPLK NewSPLUNK INC$4,036,50027,600
+100.0%
1.87%
AXSM BuyAXSOME THERAPEUTICS INC$3,981,214
+12.2%
56,964
+15.3%
1.84%
+13.5%
NewSTRUCTURE THERAPEUTICS INCsponsored ads$3,773,02974,832
+100.0%
1.75%
AMED NewAMEDISYS INC$3,665,95039,250
+100.0%
1.70%
IDYA NewIDEAYA BIOSCIENCES INC$3,422,278126,845
+100.0%
1.58%
LEGN BuyLEGEND BIOTECH CORPsponsored ads$2,975,967
+18.5%
44,305
+21.8%
1.38%
+19.8%
MRUS BuyMERUS N V$2,891,639
+222.8%
122,631
+260.4%
1.34%
+226.3%
BuyARCELLX INC$2,799,645
+40.8%
78,028
+24.1%
1.30%
+42.4%
IMGN NewIMMUNOGEN INC$2,297,532144,772
+100.0%
1.06%
AMAM BuyAMBRX BIOPHARMA INCsponsored ads$2,227,562
-11.8%
193,701
+26.2%
1.03%
-10.8%
IONS NewIONIS PHARMACEUTICALS INC$2,200,86748,520
+100.0%
1.02%
INSM NewINSMED INC$2,020,00080,000
+100.0%
0.94%
V BuyVISA INC$2,007,297
+4.0%
8,727
+7.4%
0.93%
+5.2%
DVAX NewDYNAVAX TECHNOLOGIES CORP$1,964,410133,000
+100.0%
0.91%
XPO BuyXPO INC$1,954,598
+63.4%
26,180
+29.1%
0.90%
+65.4%
BuyIMMUNEERING CORP$1,954,660
-23.8%
254,513
+0.6%
0.90%
-22.9%
MU NewMICRON TECHNOLOGY INC$1,918,44628,200
+100.0%
0.89%
BuyENLIVEN THERAPEUTICS INC$1,701,858
-31.1%
124,587
+2.9%
0.79%
-30.3%
X NewUNITED STATES STL CORP NEW$1,393,39242,900
+100.0%
0.64%
FCNCA BuyFIRST CTZNS BANCSHARES INC Ncl a$1,326,277
+56.3%
961
+45.4%
0.61%
+58.2%
RIG BuyTRANSOCEAN LTD$1,300,669
+81.3%
158,425
+54.8%
0.60%
+83.5%
TEVA NewTEVA PHARMACEUTICAL INDS LTDsponsored ads$1,267,860124,300
+100.0%
0.59%
FISV BuyFISERV INC$1,237,251
+29.9%
10,953
+45.0%
0.57%
+31.4%
XENE BuyXENON PHARMACEUTICALS INC$1,204,311
+78.0%
35,255
+100.6%
0.56%
+79.7%
BBIO NewBRIDGEBIO PHARMA INC$1,175,36444,572
+100.0%
0.54%
BuyGENERAL ELECTRIC CO$1,096,766
+46.4%
9,921
+45.4%
0.51%
+48.1%
TVTX BuyTRAVERE THERAPEUTICS INC$1,094,256
+180.5%
122,400
+381.9%
0.51%
+184.3%
LAD BuyLITHIA MTRS INC$1,093,016
+15.9%
3,701
+19.3%
0.51%
+17.4%
PFSI BuyPENNYMAC FINL SVCS INC NEW$1,081,384
+17.1%
16,237
+23.6%
0.50%
+18.4%
SLB NewSCHLUMBERGER LTD$1,072,72018,400
+100.0%
0.50%
WCC BuyWESCO INTL INC$991,926
+10.9%
6,897
+38.0%
0.46%
+12.2%
WDC NewWESTERN DIGITAL CORP.$917,16320,100
+100.0%
0.42%
CHK BuyCHESAPEAKE ENERGY CORP$880,926
+33.0%
10,216
+29.1%
0.41%
+34.7%
TPX NewTEMPUR SEALY INTL INC$862,46619,900
+100.0%
0.40%
TECK BuyTECK RESOURCES LTDcl b$860,163
+28.0%
19,962
+25.1%
0.40%
+29.6%
BuyRXO INC$802,676
+6.1%
40,683
+21.9%
0.37%
+7.5%
LLY NewELI LILLY & CO$751,9821,400
+100.0%
0.35%
HLT NewHILTON WORLDWIDE HLDGS INC$720,8644,800
+100.0%
0.33%
HCA BuyHCA HEALTHCARE INC$716,048
-2.1%
2,911
+20.7%
0.33%
-1.2%
SE BuySEA LTDsponsord ads$678,632
-1.3%
15,441
+30.4%
0.31%0.0%
SEAS BuySEAWORLD ENTMT INC$670,070
-10.0%
14,488
+9.0%
0.31%
-9.1%
CZR NewCAESARS ENTERTAINMENT INC NE$658,17014,200
+100.0%
0.30%
ANTM NewELEVANCE HEALTH INC$609,5881,400
+100.0%
0.28%
UNH NewUNITEDHEALTH GROUP INC$605,0281,200
+100.0%
0.28%
RTX NewRTX CORPORATION$582,9578,100
+100.0%
0.27%
AKRO NewAKERO THERAPEUTICS INC$577,01711,408
+100.0%
0.27%
UBER NewUBER TECHNOLOGIES INC$574,87512,500
+100.0%
0.27%
ASND BuyASCENDIS PHARMA A/Ssponsored adr$552,289
+48.2%
5,898
+41.3%
0.26%
+50.6%
CPT NewCAMDEN PPTY TRsh ben int$548,5645,800
+100.0%
0.25%
TRU NewTRANSUNION$545,6047,600
+100.0%
0.25%
CERE NewCEREVEL THERAPEUTICS HLDNG I$543,28324,887
+100.0%
0.25%
RARE BuyULTRAGENYX PHARMACEUTICAL IN$520,169
+53.9%
14,591
+99.2%
0.24%
+55.5%
UTHR BuyUNITED THERAPEUTICS CORP DEL$519,275
+35.0%
2,299
+32.0%
0.24%
+36.4%
KRYS BuyKRYSTAL BIOTECH INC$509,472
+71.5%
4,392
+73.6%
0.24%
+73.5%
RVMD NewREVOLUTION MEDICINES INC$498,37818,005
+100.0%
0.23%
ITCI NewINTRA-CELLULAR THERAPIES INC$497,1999,545
+100.0%
0.23%
NewTKO GROUP HOLDINGS INCcl a$496,5425,907
+100.0%
0.23%
BuyAMYLYX PHARMACEUTICALS INC$482,450
+62.7%
26,349
+91.7%
0.22%
+64.0%
GLPG NewGALAPAGOS NVspon adr$471,50413,647
+100.0%
0.22%
PNT NewPOINT BIOPHARMA GLOBAL INC$465,19269,744
+100.0%
0.22%
TAL NewTAL EDUCATION GROUPsponsored ads$458,23350,300
+100.0%
0.21%
MDGL BuyMADRIGAL PHARMACEUTICALS INC$444,692
-31.1%
3,045
+8.9%
0.21%
-30.4%
NTRA BuyNATERA INC$445,421
+26.2%
10,066
+38.7%
0.21%
+27.2%
PRTA BuyPROTHENA CORP PLC$443,659
+1.4%
9,195
+43.5%
0.20%
+2.5%
FDMT New4D MOLECULAR THERAPEUTICS IN$425,42433,419
+100.0%
0.20%
GERN BuyGERON CORP$425,893
+8.1%
200,893
+63.7%
0.20%
+9.4%
VERA NewVERA THERAPEUTICS INCcl a$423,66630,902
+100.0%
0.20%
NewNEW ORIENTAL ED & TECHNOLOGYspon adr$374,7206,400
+100.0%
0.17%
PTCT NewPTC THERAPEUTICS INC$296,64113,237
+100.0%
0.14%
MORF NewMORPHIC HLDG INC$235,44610,277
+100.0%
0.11%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRANSDIGM GROUP INC29Q2 20232.9%
VANGUARD INDEX FDS24Q4 201926.4%
APPLE INC24Q4 20192.0%
ISHARES TR22Q3 20187.9%
MICROSOFT CORP21Q3 20232.0%
VISA INC20Q3 20235.8%
INVESCO DB COMMDY INDX TRCK20Q3 202316.6%
VERIZON COMMUNICATIONS INC20Q4 20190.4%
ALIBABA GROUP HLDG LTD19Q3 20237.7%
AMAZON COM INC19Q3 20232.9%

View HighVista Strategies LLC's complete holdings history.

Latest significant ownerships (13-D/G)
HighVista Strategies LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
STG Group, Inc.Sold outFebruary 16, 201600.0%
SAExploration Holdings, Inc.February 12, 201425,0000.2%
Trio Merger Corp.February 14, 2013690,0008.8%

View HighVista Strategies LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View HighVista Strategies LLC's complete filings history.

Compare quarters

Export HighVista Strategies LLC's holdings